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OBJECTIVE—In theemergencydepartment,hyperglycemicpatientsarescreenedfor diabetic
ketoacidosis (DKA) via a urine dipstick. In this prospective study, we compared the test char-
acteristics of point-of-care b-hydroxybutyrate (b-OHB) analysis with the urine dipstick.
RESEARCH DESIGN AND METHODS—Emergency-department patients with blood
glucose $250 mg/dL had urine dipstick, chemistry panel, venous blood gas, and capillary
b-OHB measurements. DKA was diagnosed according to American Diabetes Association
criteria.
RESULTS—Of 516 hyperglycemic subjects, 54 had DKA. The urine dipstick had a sensitivity
of 98.1% (95% CI 90.1–100), a speciﬁcity of 35.1% (30.7–39.6), a positive predictive value of
15% (11.5–19.2), and a negative predictive value of 99.4% (96.6–100) for DKA. Using the
manufacturer-suggested cutoff of .1.5 mmol/L, b-OHB had a sensitivity of 98.1% (90.1–
100), a speciﬁcity of 78.6% (74.5–82.2), a positive predictive value of 34.9% (27.3–43), and a
negative predictive value of 99.7% (98.5–100) for DKA.
CONCLUSIONS—Point-of-care b-OHB and the urine dipstick are equally sensitive for
detecting DKA (98.1%). However, b-OHB is more speciﬁc (78.6 vs. 35.1%), offering the poten-
tial to signiﬁcantly reduce unnecessary DKA work-ups among hyperglycemic patients in the
emergency department.
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R
apid and accurate identiﬁcation of
patients with diabetic ketoacidosis
(DKA) is critical but is complicated
by the fact that DKA only affects a small
percentage of the total number of patients
with hyperglycemia (1,2). Current clini-
cal practice in the emergency department
is to screen hyperglycemic patients with a
urine dipstick for ketones and conduct a
laboratory evaluationforDKAonpatients
whose results screen positive (3). Al-
though the urine dipstick is easily acces-
sible, inexpensive, rapid, and has
excellent sensitivity for DKA, its poor
speciﬁcity (estimated at ,50%) results
in a large number of false-positive tests
and unnecessary work-ups (4). This has
led the American Diabetes Association
(ADA) to discourage using the urine dip-
stick and encourage using serum ketones
for DKA screening (5). The development
of point-of-care b-hydroxybutyrate
(b-OHB) devices has made following
these ADA recommendations feasible in
the emergency department (6). The goal
of this prospective study was to compare
the test characteristics of a point-of-care
b-OHB meter with the urine dipstick
for screening for DKA at emergency-
department triage.
RESEARCH DESIGN AND
METHODS
Setting
Thisprospective, observationalstudywas
conducted at a large, urban emergency
department. Institutional review board
approval was obtained, and study partic-
ipants provided written informed consent.
The cohort studied represents a conve-
nience sample of emergency-department
patients with triage capillary blood glu-
cose $2 5 0m g / d Le n r o l l e do n3 2 0i n d i -
vidualdays overa2-yearperiodbasedon
research-assistant availability. Subjects
were excluded if they were 1) critically ill,
2)inpolicecustody,3)sufferingfromacute
psychosis, or 4) unable to give informed
consent.
Study procedures and data collection
Included patients had a urine dipstick
(Siemens Multistix 10SG) for ketones
(recordedaspositiveornegative),aserum
chemistry panel, a venous blood gas to
determine serum pH, and a point-of-care
capillary b-OHB measurement (Precision
Xtra meter; Medisense/Abbott Laborato-
ries). DKA was deﬁned according to the
following ADA criteria: serum glucose
$250 mg/dL; anion gap .10 mmol/L;
carbon dioxide #18 mmol/L; and pH
#7.30 (7). Subjects’ race, ethnicity, age,
sex, previous history of diabetes, and in-
sulin use were recorded.
Sample size considerations
On the basis of previous literature, we
assumed that the true sensitivity of
b-OHB for detecting DKA was between
98 and 100% and determined that a sam-
pleincluding54casesofDKAwouldcon-
ﬁrm this point estimate with a conﬁdence
limit no lower than 90% (8–12). The
study wasstopped after the 54th DKA pa-
tient was enrolled.
Statistical analysis
Data were analyzed using Stata version
10.0 (StataCorp, College Station, TX).
Diagnostic test characteristics with 95%
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BRIEF REPORTCIs were calculated. According to the
manufacturer’s guidelines, point-of-care
b-OHB #1 . 5m m o l / Lw a sc o n s i d e r e d
negative and .1.5 mmol/L was consid-
ered positive. The difference in speciﬁcity
for b-OHB and urine dipstick ketones
was assessed using the McNemar test
with a Yates correction (13). We explored
the optimal capillary b-OHB cutoff by
creating areceiver-operator curveand an-
alyzing diagnostic test characteristics at
various cutoffs.
RESULTS
Participants
Atotalof859patients werescreened,616
provided informed consent, and 516
(83.7%) had all data elements necessary
for data analysis (excluded patients: 49
with no urine dipstick, 30 with no serum
pH via venous blood gas, and 21 with no
serum chemistry panel). In our ﬁnal
sample, 54 of 516 subjects (10.5%) met
the ADA criteria for DKA. See Table 1 for
sample characteristics.
Diagnostic accuracy
At the manufacturer-suggested cutoff of
.1.5 mmol/L, the sensitivity of capillary
b-OHB and the urine dipstick for DKA
were identical at 98.1% (95% CI 90.1–
100). However, the speciﬁcity of b-OHB
was signiﬁcantly higher than that of the
urine dipstick (78.6 [74.5–82.2] vs.
35.1% [30.7–39.6]; P , 0.01). Positive
andnegativepredictivevalues ofcapillary
b-OHB were 34.9 (27.3–43) and 99.7%
(98.5–100), respectively. Positive and
negative predictive values of the urine
dipstick were 15 (11.5–19.2) and 99.4%
(96.6–100), respectively. Test character-
istics of b-OHB were stable across a wide
range of potential cutoffs (Table 1). The
receiver-operatorcurvesuggestedthatthe
optimal b-OHB cutoff is .2m m o l / L ,
wheresensitivityremainsat98.1%butspec-
iﬁcity improves to 82.3% (Supplementary
Data).
CONCLUSIONS—Approximately
one-fourth of emergency-department pa-
tients have diabetes, and almost half have
poor glycemic control (2). Common clin-
ical emergency-department practice is to
consider the diagnosis of DKA in all pa-
tients presenting with blood glucose
$250 mg/dL regardless of the reason for
the visit. Because emergency-department
overcrowding has stretched resources to
thebreakingpoint,thereisincreasingem-
phasis on developing, testing, and using
the most rapid, accurate, and easy-to-use
DKA screening tool available. The results
of this study show that the speciﬁcity of
capillary point-of-care b-OHB is superior
to the urine dipstick.
Two retrospective emergency-
department studies have shown that
capillary point-of-care b-OHB is 100%
sensitive for DKA (8,9). Charles et al. (10)
likewisefound thatb-OHBwas 100%sen-
sitive in a prospective study of seven DKA
patients. Naunheim et al. (11) reported a
b-OHBsensitivityforDKAof98%inapro-
spective sample of 160 patients (57 with
DKA). Our study is the ﬁrst to prospec-
tively compare the test characteristics of
point-of-careb-OHBagainsttheurinedip-
stick in a cohort of emergency-department
patients. Using b-OHB in lieu of the urine
dipstick to screen our sample could have
reduced full laboratory work-ups for DKA
by 56.9%.
Our study has several limitations.
First, we did not provide speciﬁc training
to the nurses who interpreted the urine
dipsticks. We felt this was unnecessary
because they 1) are Clinical Laboratory
Improvement Amendment certiﬁed, 2)
are familiar and comfortable with this
process, and 3) do so regularly in routine
clinical practice. Second, the urine dip-
stickwasconsideredonlynegativeorpos-
itive, and consideration of trace/small
ketones versus moderate/large ketones
may impact the ﬁndings. Third, we did
not send blood samples to the laboratory
for an enzymatic analysis to correlate the
values measured by the point-of-care
b-OHB meter because, despite early con-
cerns, current-generation b-OHB meters
have been shown to be highly accurate
compared with laboratory enzymatic
analysis (6,14). Fourth, although there
are many ways to deﬁne DKA, we chose
to use the ADA deﬁnition because this is
commonly used in DKA literature, allow-
ing for direct comparison between our re-
sults and previous reports.
In conclusion, point-of-care capillary
b-OHBtestingatacutoffof.1.5mmol/L
was equally sensitive (98.1%) but mark-
edly more speciﬁc (78.6 vs. 35.1%) than
the urine dipstick for the detection of DKA
in our prospective sample of emergency-
department patients with hyperglycemia.
Utilizing point-of-care b-OHB testing has
the potential to substantially reduce com-
prehensive laboratory evaluations for
DKA among hyperglycemic emergency-
department patients.
Acknowledgments—The authors thank Ab-
bot Laboratories for their donation of the
b-OHB test strips needed to complete this
study.
No potential conﬂicts of interest relevant to
this article were reported.
The authors alone had sole control of study
design, data collection and analysis, and dis-
semination of ﬁndings. S.A. conceived of the
project, helped design the study, and contrib-
uted to the writing and revising of the manu-
script. S.O.H. helped design the study and
assisted with collection of data. T.L. collected
Table 1—Demographic and laboratory characteristics of the study sample
DKA No DKA
n (%) 54 (10.5) 462 (89.5)
Age (years) 41 (30–48) 48 (40–57)
Female (%) 27.8 35.3
Race/ethnicity (%)
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